AlphaYou
Overview
Key stats
Fundamentals Sep 10- Open
- $24.05
- 52-wk high
- $26.87
- High
- $24.68
- 52-wk low
- $12.00
- Low
- $23.89
- Prev close
- $24.34
- Mkt cap
- $3.88B
- Volume
- 1.11M
- Beta
- 2.10
- P/S
- 12.6x
- P/B
- 27.1x
- Profit margin
- -20.7%
- Op margin
- -22.0%
- ROE
- -38.8%
What do analysts expect?
Analyst target and ratings are on paid plans
See the 12-month consensus target and the buy/hold/sell rating split.
Unlock the full resultsSmart money
8 funds hold a position and insiders have been net selling.
What funds are doing
Activist stakes, short interest & more
Earnings
Earnings came in 30.8% below what analysts expected.
Earnings per share
-$0.13 expected
What the street expects next
EPS expected
-$0.11 to -$0.08
Revenue expected
7 analysts
Last 30 days
Analysts raising estimates
Estimate drift
Change in 30 days
Financials
What it sold, what it cost, what was left.
| USD | Sep 2025 | Dec 2025 | Mar 2026 | Jun 2026 |
|---|---|---|---|---|
| What came in | ||||
| Revenue | $94.0M | $71.7M | $70.9M | $71.6M |
| Cost of what it sold | $18.2M | $18.2M | $18.7M | $20.6M |
| Gross profit | $75.8M | $53.5M | $52.2M | $51.0M |
| What it spent | ||||
| Research and development | $23.7M | $21.8M | $23.6M | $19.2M |
| Sales and admin | $18.0M | $19.6M | $21.0M | $21.2M |
| Other operating costs | $23.9M | $24.9M | $26.8M | $26.4M |
| Total operating expenses | $65.5M | $66.2M | $71.4M | $66.7M |
| What was left | ||||
| Operating profit | $10.3M | -$12.8M | -$19.2M | -$15.8M |
| Interest on debt | $3.0M | $3.0M | $2.9M | $2.7M |
| Profit before tax | $9.5M | -$13.6M | -$20.0M | -$39.9M |
| Net profit | $9.5M | -$13.6M | -$20.0M | -$39.8M |
| EBITDA | $16.9M | -$6.4M | -$14.4M | -$12.1M |
Technicals
Price structure
This stock's price action is mixed.
Trend
Mixed
45 / 100
RSI 14
20D volatility
52-week range
20D support
20D resistance
Returns
Price vs moving averages
Volume pace
News
What the news says
Coverage is bullish
Tone of tracked coverage
Adaptive Biotechnologies director Owen sells $249,990 in stock. By Investing.com
NeutralAug 28Adaptive Biotechnologies stock hits 52-week high at $26.63
BullishAug 27
Macro
10 macro signals shaping ADPT right now
Unlock sector rotation, regime shifts, and macro event windows tied to this stock.
Unlock the full results